Navigation Links
Vertex in Medical News

Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.

BENSALEM, Pa., April 21 /PRNewswire/ -- Law Offices of Howard G. Smith announces a May 12, 2008, deadline to move to be a lead plaintiff in the securities class action lawsuit filed on behalf of all persons who purchased the publicly traded securities of Vertex Pharmaceuticals Inc. ("Vertex" o...

Dreier LLP Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated (VRTX)

NEW YORK, March 20 /PRNewswire/ -- Dreier LLP (http://www.dreierllp.com ) announces that a class action lawsuit was commenced in the U.S. District Court for the District of Massachusetts on behalf of investors who purchased Vertex Pharmaceuticals Incorporated ("Vertex" or the "Company") (Nasd...

Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated

BENSALEM, Pa., March 19 /PRNewswire/ -- Law Offices of Howard G. Smith announces that a securities class action lawsuit has been filed on behalf of all persons who purchased the publicly traded securities of Vertex Pharmaceuticals Inc. ("Vertex" or the "Company") (Nasdaq: VRTX ) between June ...

BioMed Realty Trust Commemorates Five-Year Anniversary as a Public Company

...ences, Inc. , the company's largest tenant, raised approximately $357 million in net proceeds from its common stock offering. On July 30, 2009, vertex Pharmaceuticals Incorporated , the company's second largest tenant, announced that it will receive $105 million, in addition to potential milestone pa...

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

..., Inc., Valeant Pharmaceuticals International, and vertex Pharmaceuticals, Inc. Market data and analytics ar... 5. Drug Approvals & Clinical Trials II-54 vertex to Initiate Phase III Trial of Telaprevir II-54 ...eant Pharmaceuticals International (USA) II-78 vertex Pharmaceuticals, Inc. (USA) II-78 III. COMPE...

Case Western Reserve University Receives $5M From Third Frontier Commission for the Center for Stem Cell & Regenerative Medicine

...d to release a specific amount of drug over a prolonged period of time to tell the patient's cells to create cartilage. Bruce Trapp (CC) and vertex Pharmaceuticals of Cambridge, MA have identified a cell in the adult human brain and will evaluate its potential to treat a variety of neurodegenerati...

Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis-C Virus (HCV)

...en on its own. Based on clinical data, Telaprevir, a 3x-day oral drug from vertex Pharmaceuticals is considered the leading adjunct candidate based on outcom... by the reality that Telaprevir represents a significant value component of vertex (VRTX), which as I write this letter is valued at more $5 billion in the pu...

NEJM study points to new era in hepatitis C treatment

...0th issue of the New England Journal of Medicine . The study was funded by vertex Pharmaceuticals Incorporated, the maker of the drug telaprevir. The drug wo...ns School of Medicine; and Robert Kauffman, Lindsay McNair and John Alam of vertex Pharmaceuticals. Drs. Jacobson, McHutchison and Muir have received cons...

LaVoie Group Appointed by Mithridion as PR Agency

...ir companies through integrated communications programs. Our clients range from privately held start-ups to industry leaders in life sciences such as vertex Pharmaceuticals, ESBATech AG, and Agile Therapeutics. In March 2009, LaVoie Group was awarded the coveted 2008 Impact Award for "Best Industry-E...

BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results

...rimarily of the previously announced extensions through 2015 of two leases totaling approximately 292,800 square feet in Cambridge, Massachusetts with vertex Pharmaceuticals Inc., including its corporate headquarters. Completed construction and development of the Center for Life Sc...
Vertex in Medical Technology

Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP

RADNOR, Pa., April 18 /PRNewswire/ -- The following statement was issued today by the law firm of Schiffrin Barroway Topaz & Kessler, LLP: Notice is hereby given that a class action lawsuit was filed in the United States District Court for the District of Massachusetts on behalf of all purch...

R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023

...ug. In the single-dose study, 2 ml of RK-023 preparation was applied to the vertex region of 6 out of 9 healthy adult males and a placebo to that of the remaining 3 subjects. The applied drug was spread widely covering the vertex region in order to investigate the safety in the entire body and scalp. No ...

Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs

... In June 2009, the IND-enabling safety studies were completed for the FSMA-directed Quinazoline program. This is the program previously worked on by vertex Pharmaceuticals and deCODE genetics, and fully funded by Families of SMA. The next step for this program is to request a pre-IND meeting with th...

Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF

...51D mutation of CF. The drug is being developed by vertex Pharmaceuticals Incorporated. Patients who took ...ndation approached Aurora Biosciences (acquired by vertex in 2001) and made an initial investment to use cut...s," said Joshua Boger, Ph.D., president and CEO of vertex Pharmaceuticals. "The project carried significant ...

Vertex Pharmaceuticals Announces New Data for Investigational HCV Protease Inhibitor Telaprevir to be Presented at 42nd Annual Meeting of the European Association for the Study of the Liver (EASL)

...an Summer Time (11:45 a.m. Eastern Daylight Time). vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) is dev...iver-meeting. Webcast of Investor Presentation vertex intends to provide a live webcast of its investor ...ents in development that specifically targets HCV. vertex is conducting a global Phase 2b clinical developme...

Interim Results Presented at EASL from PROVE 1 Clinical Trial of Investigational Drug Telaprevir in Patients with Genotype 1 Hepatitis C

...s for Clinical Development and Registration Path vertex today discussed the potential implications that th...has for future clinical development of telaprevir. vertex stated its intention to consider evaluation of tre...ng on PROVE 2 data, regimens that may exclude RBV. vertex expects to focus on treatment durations of no more...
Vertex in Medical Products

Vertex Toric

Description:...ant crisp, clear vision with the convenience of a disposable lens, consider vertex Toric. vertex Toric lenses are manufactured using our patented UltraSync technology, a pr...
Company:CooperVision

Vertex Toric®

Description:...ant crisp, clear vision with the convenience of a disposable lens, consider vertex Toric. vertex Toric lenses are manufactured using our patented UltraSync® technology,...
Company:CooperVision

Vertex Reconstruction System

Features:... bony attachment with a variety of attachment mechanisms, such as multi-axial screws, hooks, and lateral offset connectors, which attach to a rod. The vertex Reconstruction System is cleared for C1 - T3 Laminar Hook placement and T1 - T3 pedicle screws. This System is intended for posterior use only....
Company:Medtronic Neurological and Spinal

KOWA Refkeratometer KW-2000

Features:... 2.3 mm pupil size eye with IOL can be measured. Automatic PD measurement, vertex distance compensation (0, 10, 12, 13.5, 15mm). Simultanious Ref/Keratometer readings or set for Refactor or Keratometer individually. ...
Company:Kowa Optimed, Inc

Khosla Non-Illuminated Trial Lens Set, With Lenses Mounted

Features:... Packed in portable leather case. Attractive set of trial lenses worked to a high standard of accuracy. The lenses are of plano form, back vertex power, 20 mm aperture spun into plastic mounts of 38 mm diameter. Plus and minus mounts are in different colors. Handles are provided on spheres, but ...
Company:Khosla Medical & Surgical, Inc.

Illuminated Trial Lens Set

Features:... Lenses are of plano form, back vertex power, 20 mm aperture spun into aluminum mounts Of 38 mm diameter. Plus and minus mounts are anodized in different colors. Handles are provided on sph...
Company:Khosla Medical & Surgical, Inc.

Non-Illuminated Trial Lens Set

Features:... Lenses are of plano form, back vertex power, 20 mm aperture spun into aluminum mounts Of 38 mm diameter. Plus and minus mounts are anodized in different colors. Handles are provided on sph...
Company:Khosla Medical & Surgical, Inc.
Vertex in Biological News

CWRU receives $5 million from Ohio Third Frontier Commission

...tuned to release a specific amount of drug over a prolonged period of time to tell the patient's cells to create cartilage. Bruce Trapp (CC) and vertex Pharmaceuticals of Cambridge, MA have identified a cell in the adult human brain and will evaluate its potential to treat a variety of neurodegenerati...

Nano-softball made of DNA

...onnected together at one point). The centers of these building blocks represent the vertices of the dodecahedron. The three edges projecting from each vertex are formed when a single strand of DNA converts two neighboring bridging components into a double strand. In order for this process to result in a ...
Vertex in Biological Technology

BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015

SAN DIEGO, Jan. 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR ) announced today the signing of two lease extensions in Cambridge, Massachusetts with Vertex Pharmaceuticals Incorporated, totaling over 292,000 square feet at BioMed's 40 Erie Street (also known as Vertex's Corpo...

Shire begins the year with a strong performance

...mpleted the disposal of its minority equity investment in Virochem to vertex Pharmaceuticals Inc., ("Vertex") in a cash and stock transaction. Shi...e received total consideration of $19 million in cash and two million vertex shares from the disposal, recognizing a gain of $55 million in Q1 200...

LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record

...ir companies through integrated communications programs. Our clients range from privately held start-ups to industry leaders in life sciences such as vertex Pharmaceuticals, ESBATech AG, and Agile Therapeutics. In March 2009, LaVoie Group was awarded the coveted 2008 Impact Award for "Best Industry-E...

LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster

...ions programs. In addition to Pegasus, our clients range from privately held development stage companies to industry leaders in life sciences such as vertex Pharmaceuticals, ESBATech AG, and Agile Therapeutics. In March 2009, LaVoie Group was awarded the coveted 2008 Impact Award for "Best Industry-E...

Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft

...atisfying regulatory mandates. Some of the world's leading global companies including Pfizer Inc., Johnson & Johnson, Novartis, Eli Lilly and vertex Pharmaceuticals look to Intrasphere as their trusted solutions partner. Founded in 1996, Intrasphere is headquartered in New York City with opera...

MichBio Announces Annual Business Meeting Keynote and Pre-Meeting Workshop

... and CEO of CovX Pharmaceuticals. Dr. Stylli co-founded Aurora Biosciences in 1995, and in 2001 he was key to the success of Aurora's acquisition by vertex Pharmaceuticals. Following the merger, Dr. Stylli continued on with the company as president of Aurora Biosciences and Panvera. From 1987 to 1995, Dr...

Beacon Equity Issues Technical Trade Alerts on Drug Manufacturer Stocks: FRX, TEVA, AGN, CEPH, VRTX, ADLR

...aboratories Inc. (NYSE: FRX ), Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ), Allergan Inc. (NYSE: AGN ), Cephalon Inc. (Nasdaq: CEPH ), vertex Pharmaceuticals Inc. (Nasdaq: VRTX ) and Adolor Corp. (Nasdaq: ADLR ). Join the fastest growing investment community at: http://www.stockh...

Shire plc: Change to Director's Details

...ew Emmens, non-executive Chairman of Shire, has been appointed President of vertex Pharmaceuticals Incorporated with immediate effect and that Mr Emmens will in addition become Chairman and Chief Executive Officer of vertex in May 2009 when the current Chief Executive Officer retires. This ...

BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World

...lobe. "Improving health care in developing nations is a goal that all biotechnology companies share," said Joshua Boger, Ph.D., President and CEO of vertex Pharmaceuticals Incorporated, and Chairman of the Biotechnology Industry Organization (BIO). "Biotechnology innovation has dramatically changed the li...

Dr. Charles Sanders to Become Lead Director of Epiphany Biosciences

...fficer of Glaxo Inc., from 1989-1994 and chairman of the board from 1992-1995. In addition, Dr. Sanders is also a member of the Boards of Directors of vertex Pharmaceuticals, Cephalon, Inc., and Icagen, Inc. "The Epiphany strategy of addressing long-term disease as sequelae of chronic viral infection offe...
Vertex in Biological Dictionary

Parallelism

... Angle of parallelism , the angle at one vertex of a right hyperbolic triangle ... Conscious parallelism , price-fixing between competitors in an oligopoly that ... Parallel computing is a for...
Other Tags
(Date:10/20/2014)... Collins, CO (PRWEB) October 20, 2014 ... dGH assays are the only imaging assays capable ... in a single test.  With these three dimensions ... their ability to detect the widest range of ... translocations—mutations usually missed by other genomic tools, including ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The ... member hospital ROI on membership dues at 12.5. In other ... $12.50 in value to member hospitals. The calculation used to ... Dues. , “This is the first time we’ve actually ... the methodology is really sound,” said Bill Ryan , ...
(Date:10/20/2014)... Houston plastic surgeon Dr. Christopher ... of his innovative True Form Tummy Tuck® ... and faculty at The University of Texas Medical ... once a medical student. Patronella, who is a founding ... surgery practices in Texas, The Aesthetic Center for ...
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, has recently announced ... the best Dedicated Server Hosting suppliers. Their websites ... buy high quality hosting and save money at ... Top10BestSEOHosting.com says, “We believe that iPage and GreenGeeks ... lot of the global clients enjoy using their ...
(Date:10/19/2014)... 20, 2014 This report provides ... Seizure, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ... press releases. It also reviews key players involved ... special features on late-stage and discontinued projects. , ...
Breaking Medicine News(10 mins):Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4
(Date:10/15/2014)... Conn. , Oct. 15, 2014 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce market releases ... MarketSite in Times Square on Monday October 13 th . ... CTO David Tunnel and angel investor Mr. Chad ... Pereira , CEO of NXT-ID thanked his investors and employees "for ...
(Date:10/14/2014)... (Oct. 14, 2014)—It,s been millions of years since ... team led by Ohio University scientists is breathing life ... airflow through dinosaur snouts. The research has important implications ... breathe but to enhance the sense of smell and ... animals," said Ohio University doctoral student Jason Bourke, lead ...
(Date:10/14/2014)... – Scientists from The Scripps Research Institute (TSRI) have ... Health (NIH) to lead an investigation of Lassa fever ... Africa. The study aims to understand how Lassa fever ... others survive the inflection. , "The ultimate goal ... how Lassa fever virus causes disease and develop new ...
Breaking Biology News(10 mins):Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3Scripps Research Institute team receives $6.6 million to investigate deadly Lassa virus 2
Other Contents